Oral lichen planus
- PMID: 32753462
- PMCID: PMC7828879
- DOI: 10.1503/cmaj.200309
Oral lichen planus
Conflict of interest statement
Competing interests: Antoine Eskander reports receiving research funds from Merck and consulting fees from Bristol Myers Squibb in 2019. No other competing interests were declared.
Figures
References
-
- Cheng YS, Gould A, Kurago Z, et al. Diagnosis of oral lichen planus: a position paper of the American Academy of Oral and Maxillofacial Pathology. Oral Surg Oral Med Oral Pathol Oral Radiol 2016;122:332–54. - PubMed
-
- Alrashdan MS, Cirillo N, McCullough M. Oral lichen planus: a literature review and update. Arch Dermatol Res 2016;308:539–51. - PubMed
-
- Giuliani M, Troiano G, Cordaro M, et al. Rate of malignant transformation of oral lichen planus: a systematic review. Oral Dis 2019;25:693–709. - PubMed
-
- Warnakulasuriya S, Ariyawardana A. Malignant transformation of oral leukoplakia: a systematic review of observational studies. J Oral Pathol Med 2016;45:155–66. - PubMed
-
- Gupta S, Ghosh S, Gupta S. Interventions for the management of oral lichen planus: a review of the conventional and novel therapies. Oral Dis 2017;23:1029–42. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources